Thomas Krogh
Chief Operating Officer chez VERITAS FARMS, INC.
Profil
Thomas J.
Krogh is currently the Chief Operating Officer at Veritas Farms, Inc. He previously worked as the Finance Director at CBR International Corp.
He completed his undergraduate degree at the University of Denver.
Postes actifs de Thomas Krogh
| Sociétés | Poste | Début |
|---|---|---|
| VERITAS FARMS, INC. | Chief Operating Officer | 25/08/2023 |
Anciens postes connus de Thomas Krogh
| Sociétés | Poste | Fin |
|---|---|---|
CBR International Corp.
 CBR International Corp. Miscellaneous Commercial ServicesCommercial Services Part of Novotech Holdings Pty Ltd., Novotech Drug Development Consulting (formerly CBR International Corp.) is a full-service product development, clinical oversight, and regulatory operations group. The private company is based in Boulder, CO. CBR International was acquired by Novotech Holdings Pty Ltd. on January 09, 2023. Novotech Drug Development Consulting provides comprehensive "lab to launch" program development services and is currently assisting companies with COVID-19 development programs and FDA's Coronavirus Treatment Acceleration Program (CTAP). The company was founded in 1999 by Jeanne M. Novak, who has been the CEO since 1999. | Corporate Officer/Principal | - |
Formation de Thomas Krogh
| University of Denver | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VERITAS FARMS, INC. | Process Industries |
| Entreprise privées | 1 |
|---|---|
CBR International Corp.
CBR International Corp. Miscellaneous Commercial ServicesCommercial Services Part of Novotech Holdings Pty Ltd., Novotech Drug Development Consulting (formerly CBR International Corp.) is a full-service product development, clinical oversight, and regulatory operations group. The private company is based in Boulder, CO. CBR International was acquired by Novotech Holdings Pty Ltd. on January 09, 2023. Novotech Drug Development Consulting provides comprehensive "lab to launch" program development services and is currently assisting companies with COVID-19 development programs and FDA's Coronavirus Treatment Acceleration Program (CTAP). The company was founded in 1999 by Jeanne M. Novak, who has been the CEO since 1999. | Commercial Services |
